InSilicoTrials is thrilled to announce the publication of "𝐓𝐨𝐰𝐚𝐫𝐝 𝐆𝐨𝐨𝐝 𝐒𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞 - 𝐁𝐞𝐬𝐭 𝐩𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐮𝐬𝐞 𝐨𝐟 𝐜𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐦𝐨𝐝𝐞𝐥𝐥𝐢𝐧𝐠 & 𝐬𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐨𝐟 𝐛𝐢𝐨𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬" a crucial document guiding the use of simulation data & evidence in the regulatory process of biomedical products.

This work is the culmination of a global collaboration among in silico experts, coordinated by the In Silico World consortium, with significant contributions from the Avicenna Alliance, VPH Institute, and FDA professionals.

Published in open access by Springer Nature Group, the book is edited by Prof. Marco Viceconti and InSilicoTrials' CEO Luca Emili, addressing the need for standardized practices within the in silico field.

Our strong belief is anchored in the insightful foreword by Pras Pathmanathan from the Office of Science and Engineering Laboratories, Center for Devices and Radiological Health at the FDA, suggesting a future where these words manifest into reality "… 𝘪𝘵 𝘪𝘴 𝘩𝘰𝘱𝘦𝘥 𝘵𝘩𝘢𝘵 𝘵𝘩𝘪𝘴 𝘣𝘰𝘰𝘬 𝘸𝘪𝘭𝘭 𝘴𝘵𝘪𝘮𝘶𝘭𝘢𝘵𝘦 𝘧𝘶𝘳𝘵𝘩𝘦𝘳 𝘤𝘰𝘯𝘷𝘦𝘳𝘴𝘢𝘵𝘪𝘰𝘯𝘴 𝘢𝘮𝘰𝘯𝘨𝘴𝘵 𝘢𝘭𝘭 𝘴𝘵𝘢𝘬𝘦𝘩𝘰𝘭𝘥𝘦𝘳𝘴 𝘢𝘯𝘥 𝘶𝘭𝘵𝘪𝘮𝘢𝘵𝘦𝘭𝘺 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘦 𝘵𝘰 𝘵𝘩𝘦 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘰𝘧 𝘤𝘰𝘮𝘮𝘶𝘯𝘪𝘵𝘺-𝘢𝘤𝘤𝘦𝘱𝘵𝘦𝘥 𝘎𝘰𝘰𝘥 𝘚𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯 𝘗𝘳𝘢𝘤𝘵𝘪𝘤𝘦, 𝘣𝘳𝘪𝘯𝘨𝘪𝘯𝘨 𝘔&𝘚 𝘧𝘰𝘳 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘴 𝘵𝘰 𝘮𝘢𝘵𝘶𝘳𝘪𝘵𝘺."

Please find below the book's index and an overview of the chapters' content:

  1. Introduction
  2. Theoretical Foundations of GSP
  3. Model Development
  4. Model Credibility
  5. Possible Qualification Pathways for In Silico Methodologies
  6. Possible Health Technology Assessment Pathways
  7. Ethical Review of In Silico Methodologies
  8. The Sponsor
  9. The Investigator: modellers and analyst 

Link to freely download the book: https://link.springer.com/book/10.1007/978-3-031-48284-7

If you're seeking more details or interested in exploring how this groundbreaking publication can enhance your biosimulation strategies, don't hesitate to get in touch. Our InSilicoTrials experts are ready to assist you in understanding the implications of Good Simulation Practice (GSP) for your projects, illustrating best practices, and demonstrating use cases to maximize GSP's benefits for your drug development endeavors.